Over ten percent of the U.S. population suffers from migraines, and currently-approved treatments are not always effective and can produce adverse effects. Now, migraine sufferers may be able to get some relief from a newly FDA-approved device. The device is made by a Belgian company, Cephaly
A special joint panel of the Stroke and Heart Associations issued gender-focused guidelines on reducing the toll of strokes among women. In their vast literature review, surprising focus is on younger women.